← Back
Data updated: Mar 10, 2026
B BRAUN MEDICAL
NeurologyInfectious DiseaseDermatology
B BRAUN MEDICAL is a pharmaceutical company focused on Neurology, Infectious Disease, Dermatology. Key products include PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER.
2015
Since
16
Drugs
-
Trials
52
Approved (2yr)
Key Drugs
Recent Activity
HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
MAGNESIUM SULFATE 2026-01-08
Manufacturing (CMC)
ROCURONIUM BROMIDE 2026-01-06
ACETAMINOPHEN 2025-12-05
ROCURONIUM BROMIDE 2025-10-24
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
HEPARIN SODIUM 2025-09-24
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 32%
3 drugs
Infectious Disease 25%
2 drugs Phase 1: 2
Dermatology 21%
2 drugs
Cardiovascular 11%
1 drugs
Metabolic 11%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
B BRAUN specialty
Infectious Disease, Dermatology, Metabolic, Cardiovascular
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Infectious Disease, Neurology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology
Active (10)
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER TROMETHAMINE SUGAMMADEX SODIUM CALCIUM GLUCONATE MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER LEVETIRACETAM IN SODIUM CHLORIDE ROCURONIUM BROMIDE MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER MAGNESIUM SULFATE LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Discontinued (6)
Company Info
- First Approval
- 2015-04-30
- Latest
- 2025-10-24
- Applications
- 16